Development of retinol-binding protein 4 immunocolloidal gold fast test strip using high-sensitivity monoclonal antibodies generated by DNA immunization

Acta Biochimica et Biophysica Sinica

Volumn 42, Issue 12, 2010, Pages 847-853

  Bian, Chao ^a   Zhang, Fang ^b   Wang, Feng ^b   Ling, Zhiyang ^c   Luo, Min ^a   Wu, Hongqiang ^a   Sun, Yizhuo ^a   Li, Junhui ^b   Li, Bingnan ^d   Zhu, Jingyan ^d   Tang, Linna ^d   Zhou, Yanyan ^d   Shi, Qunfang ^d   Ji, Yongyong ^a   Tian, Lin ^a   Lin, Guomei ^a   Fan, Yu ^b   Wang, Niansong ^b   Sun, Bing ^a,c  

^a INSTITUTE OF BIOCHEMISTRY AND CELL BIOLOGY   (China)

^b SHANGHAI JIAO TONG UNIVERSITY   (China)

^c INSTITUTE PASTEUR OF SHANGHAI   (China)

^d Shanghai Immune Biotech Co Ltd   (China)

Author keywords

DNA immunization; immunocolloidal gold; monoclonal antibody; renal damage; retinol binding protein 4

Indexed keywords

COLLOIDAL GOLD; DIAGNOSTIC AGENT; DNA; MONOCLONAL ANTIBODY; PLASMA RETINOL BINDING PROTEIN; RBP4 PROTEIN, HUMAN;

ANALYTICAL EQUIPMENT; ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; EVALUATION; GENETICS; HUMAN; IMMUNIZATION; IMMUNOLOGY; KIDNEY DISEASE; METHODOLOGY; NUCLEOTIDE SEQUENCE; PATHOLOGY; SENSITIVITY AND SPECIFICITY; TEST STRIP;

ANTIBODIES, MONOCLONAL; BASE SEQUENCE; DNA; ENZYME-LINKED IMMUNOSORBENT ASSAY; GOLD COLLOID; HUMANS; IMMUNIZATION; KIDNEY DISEASES; REAGENT KITS, DIAGNOSTIC; REAGENT STRIPS; RETINOL-BINDING PROTEINS, PLASMA; SENSITIVITY AND SPECIFICITY;

EID: 78649650005     PISSN: 16729145     EISSN: 17457270     Source Type: Journal    
DOI: 10.1093/abbs/gmq099     Document Type: Article

References (18)

1. Tang CK and Pietersz GA. Intracellular detection and immune signaling pathways of DNA vaccines. Expert Rev Vaccines 2009, 9: 1161-1170.
2. Garren H. DNA vaccines for autoimmune diseases. Expert Rev Vaccines 2009, 9: 1195-1203.
3. Kim JH and Jacob J. DNA vaccines against influenza viruses. Curr Top Microbiol Immunol 2009, 333: 197-210.
4. Tearina Chu TH, Halverson GR, Yazdanbakhsh K, Oyen R and Reid ME. A DNA-based immunization protocol to produce monoclonal antibodies to blood group antigens. Br J Haematol 2001, 113: 32-36.
5. Chen Z, Guo X, Ge X, Chen Y and Yang H. Preparation of monoclonal antibodies against pseudorabies virus glycoprotein gC by adenovirus immunization alone or as a boost following DNA priming. Hybridoma (Larchmt) 2008, 27: 36-42.
6. Puttikhunt C, Kasinrerk W, Srisa-ad S, Duangchinda T, Silakate W, Moonsom S and Sittisombut N, et al. Production of anti-dengue NS1 monoclonal antibodies by DNA immunization. J Virol Methods 2003, 109: 55-61.
7. Goodman DS. Plasma retinol-binding protein. Ann N Y Acad Sci 1980, 348: 378-390.
8. Goodman DS. Retinoid-binding proteins in plasma and in cells. Ann N Y Acad Sci 1981, 359: 69-78.
9. Zanotti G and Berni R. Plasma retinol-binding protein: structure and interactions with retinol, retinoids, and transthyretin. Vitam Horm 2004, 69: 271-295.
10. Bernard AM, Moreau D and Lauwerys R. Comparison of retinol-binding protein and beta 2-microglobulin determination in urine for the early detection of tubular proteinuria. Clin Chim Acta 1982, 126: 1-7. (Pubitemid 13242360)
11. Bernard AM, Vyskocil AA, Mahieu P and Lauwerys RR. Assessment of urinary retinol-binding protein as an index of proximal tubular injury. Clin Chem 1987, 33: 775-779.
12. Flynn FV. Assessment of renal function: selected developments. Clin Biochem 1990, 23: 49-54.
13. Câmara NO, Silva MS, Nishida S, Pereira AB and Pacheco-Silva A. Proximal tubular dysfunction is associated with chronic allograft nephropa-thy and decreased long-term renal-graft survival. Transplantation 2004, 78: 269-275.
14. Miyazaki J and Aihara H. Gene transfer into muscle by electroporation in vivo. Methods Mol Med 2002, 69: 49-62.
15. Chen J, Fang F, Li X, Chang H and Chen Z. Protection against influenza virus infection in BALB/c mice immunized with a single dose of neuraminidase-expressing DNAs by electroporation. Vaccine 2005, 23: 4322-4328.
16. Bian C, Zhang X, Cai X, Zhang L, Chen Z, Zha Y and Xu Y, et al. Conserved amino acids W423 and N424 in receptor-binding domain of SARS-CoV are potential targets for therapeutic monoclonal antibody. Virology 2009, 383: 39-46.
17. Xue T, Xue XP, Huang QS, Wei L, Sun K and Xue T. Monoclonal antibodies against human aspartyl (asparaginyl) beta-hydroxylase developed by DNA immunization. Hybridoma (Larchmt) 2009, 28: 251-257.
18. Kirsztajn GM, Nishida SK, Silva MS, Ajzen H, Moura LA and Pereira AB. Urinary retinol-binding protein as a prognostic marker in glomerulo-pathies. Nephron 2002, 90: 424-431.